Variations in the complement regulatory genes factor H (CFH) and factor H related 5 (CFHR5) are associated with membranoproliferative glomerulonephritis type II (dense deposit disease)
暂无分享,去创建一个
J L McRae | G. Hageman | P. Zipfel | C. Skerka | G. Silvestri | C. Nishimura | Richard J. H. Smith | J. Smith | G S Hageman | R. Smith | M. Józsi | G Silvestri | R J H Smith | P F Zipfel | S. Sethi | M A Abrera-Abeleda | C Nishimura | J L H Smith | S Sethi | B F Murphy | C Skerka | M Józsi | J. McRae | B. Murphy | B. Murphy | M. A. Abrera-Abeleda | Giuliana Silvestri | R. Smith | J. Smith | Sanjjev Sethi
[1] R. Gokal,et al. Fundus changes in mesangiocapillary glomerulonephritis type II: clinical and fluorescein angiographic findings. , 1989, The British journal of ophthalmology.
[2] P. Hill,et al. Factor H-related protein-5: a novel component of human glomerular immune deposits. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[3] Wiklund Ra,et al. First of two parts , 1997 .
[4] M. Daha,et al. Differential expression of complement components in human fetal and adult kidneys. , 1996, Kidney international.
[5] C. Bazzi,et al. The prognostic value of some clinical and histological parameters in membranoproliferative glomerulonephritis (MPGN): report of 112 cases. , 1977, Nephron.
[6] D. Colville,et al. Visual impairment caused by retinal abnormalities in mesangiocapillary (membranoproliferative) glomerulonephritis type II ("dense deposit disease"). , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[7] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[8] Robert F. Mullins,et al. An Integrated Hypothesis That Considers Drusen as Biomarkers of Immune-Mediated Processes at the RPE-Bruch's Membrane Interface in Aging and Age-Related Macular Degeneration , 2001, Progress in Retinal and Eye Research.
[9] M. Gubler,et al. Dense deposit disease: a variant of membranoproliferative glomerulonephritis. , 1975, Kidney international.
[10] S. Meri,et al. Regulation of alternative pathway complement activation by glycosaminoglycans: specificity of the polyanion binding site on factor H. , 1994, Biochemical and biophysical research communications.
[11] Mark Daly,et al. Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..
[12] V. Verhasselt,et al. Regulation of C3 and factor H synthesis of human glomerular mesangial cells by IL‐1 and interferon‐gamma , 1994, Clinical and experimental immunology.
[13] Albert Hofman,et al. Epidemiology of age-related maculopathy: a review. , 2003, European journal of epidemiology.
[14] O. Spiller,et al. Decay-accelerating factor expression in the rat kidney is restricted to the apical surface of podocytes. , 2002, Kidney international.
[15] P. Mcenery. Membranoproliferative glomerulonephritis: the Cincinnati experience--cumulative renal survival from 1957 to 1989. , 1990, The Journal of pediatrics.
[16] G. Hageman,et al. Structure and composition of drusen associated with glomerulonephritis: Implications for the role of complement activation in drusen biogenesis , 2001, Eye.
[17] B S Hawkins,et al. Epidemiology of age-related macular degeneration. , 1999, Molecular vision.
[18] G. Deschênes,et al. Heterozygous and homozygous factor h deficiencies associated with hemolytic uremic syndrome or membranoproliferative glomerulonephritis: report and genetic analysis of 16 cases. , 2004, Journal of the American Society of Nephrology : JASN.
[19] A. Bird,et al. [Pathogenesis of lesions in late age-related macular disease]. , 2004, Journal francais d'ophtalmologie.
[20] C. Swainson,et al. Mesangiocapillary glomerulonephritis: A long‐term study of 40 cases , 1983, The Journal of pathology.
[21] Robert F Mullins,et al. A role for local inflammation in the formation of drusen in the aging eye. , 2002, American journal of ophthalmology.
[22] J. Gilbert,et al. Complement Factor H Variant Increases the Risk of Age-Related Macular Degeneration , 2005, Science.
[23] A. Hofman,et al. REVIEW: Epidemiology of age-related maculopathy: a review , 2003, European Journal of Epidemiology.
[24] John D Lambris,et al. Membranoproliferative glomerulonephritis type II (dense deposit disease): an update. , 2005, Journal of the American Society of Nephrology : JASN.
[25] R. Sandler,et al. Infantile cystinosis presenting as chronic constipation. , 2002, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[26] C. Antignac,et al. Glomerular lesions in the transplanted kidney in children. , 1987, American journal of kidney diseases : the official journal of the National Kidney Foundation.
[27] M. Walport,et al. Uncontrolled C3 activation causes membranoproliferative glomerulonephritis in mice deficient in complement factor H , 2002, Nature Genetics.
[28] A. Edwards,et al. Complement Factor H Polymorphism and Age-Related Macular Degeneration , 2005, Science.
[29] R. Trembath,et al. Pendred syndrome and DFNB4‐mutation screening of SLC26A4 by denaturing high‐performance liquid chromatography and the identification of eleven novel mutations , 2004, American journal of medical genetics. Part A.
[30] G. Haycock,et al. Idiopathic mesangiocapillary glomerulonephritis. Comparison of types I and II in children and adults and long-term prognosis. , 1983, The American journal of medicine.
[31] Stefan Heinen,et al. Mutations in factor H reduce binding affinity to C3b and heparin and surface attachment to endothelial cells in hemolytic uremic syndrome. , 2003, The Journal of clinical investigation.
[32] J. Ott,et al. Complement Factor H Polymorphism in Age-Related Macular Degeneration , 2005, Science.
[33] P. Zipfel,et al. The role of complement in membranoproliferative glomerulonephritis , 2006 .
[34] R. T. Smith,et al. A common haplotype in the complement regulatory gene factor H (HF1/CFH) predisposes individuals to age-related macular degeneration. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[35] M. Nangaku. Complement regulatory proteins in glomerular diseases. , 1998, Kidney international.
[36] N. Gretz,et al. Complement analysis in children with idiopathic membranoproliferative glomerulonephritis: A long‐term follow‐up , 2001, Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology.
[37] J. H. Jansen,et al. In situ complement activation in porcine membranoproliferative glomerulonephritis type II. , 1998, Kidney international.
[38] P Vivien,et al. [The nephrotic syndrome]. , 1965, Le Progres medical.